Abstract:We report a suitable patch test concentration for five fragrance materials that are then to be used in a surveillance study with patch testing consecutive patients over an extended monitoring period to evaluate the hypothesis that the quantitative risk assessment‐driven consumer product levels of these fragrances can prevent sensitization. Background Quantitative risk assessment (QRA) for skin sensitization is used to derive safe use levels of sensitising fragrance ingredients in products. Post‐marketing surveillance of the prevalence of contact allergy to these ingredients provides relevant data to help evaluate the performance of these measures. Objectives To determine a suitable patch test concentration for five fragrance materials that had hitherto not been tested on a regular basis. These concentrations are then to be used in a surveillance study with patch testing consecutive patients over an extended monitoring period. Materials and Methods Furaneol, CAS.3658‐77‐3; trans‐2‐hexenal, CAS.6728‐26‐3; 4,8‐dimethyl‐4,9‐decadienal, CAS.71077‐31‐1; longifolene, CAS.475‐20‐7; benzaldehyde, CAS.10052‐7, were patch tested with other fragrance allergens in four clinics. Patch testing was conducted in three rounds, starting with the lowest concentrations of the five ingredients. The doses were increased in the subsequent rounds if no late‐appearing positive reactions and virtually no irritant reactions were reported. Results Overall, 373 patients were tested. No positive allergic reaction was reported to the five ingredients. Patch test results of other fragrance allergens are reported. Conclusions The highest test concentrations are each considered safe for patch testing consecutive patients. Further surveillance based on these preparations will evaluate the hypothesis that QRA‐driven consumer product levels of these fragrances can prevent sensitization.

Results of patch testing with five fragrance materials hitherto not tested: A dose‐finding study in the clinical population

Fragrance Contact Allergy - A Review Focusing on Patch Testing

Contact sensitization to hydroperoxides of limonene and linalool: Results of consecutive patch testing and clinical relevance

What is the added value of patch testing with 30 fragrance allergens in addition to the European Baseline series?

Examining the benefits of extended patch test series in children: a comprehensive analysis

Recommendation to test limonene hydroperoxides 0·3% and linalool hydroperoxides 1·0% in the British baseline patch test series

A Clinical And Patch Test Study Of Patients With Positive Patch Test Reactions To Fragrance Mix In China

Quantitative risk assessments of skin sensitization for 26 allergens in different consumer products in the Saudi market

GARDskin dose-response assay and its application in conducting Quantitative Risk Assessment (QRA) for fragrance materials using a Next Generation Risk Assessment (NGRA) framework

Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato-Allergology group of the French Society of Dermatology)

Sensitizing fragrances in absorbent hygiene products

Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing

Assessment of the risk of respiratory sensitization from fragrance allergens released by air fresheners

Detection of potentially skin sensitizing hydroperoxides of linalool in fragranced products

Fragrance mix II in the baseline series contributes significantly to detection of fragrance allergy

The Safety Assessment of Cosmetic Perfumes by Using In Chemico and In Vitro Methods in Combination with GC-MS/MS Analysis

Comparative sensitizing potencies of fragrances, preservatives, and hair dyes

Sensitisation to ethylhexyl salicylate: Another piece of the frontal fibrosing alopecia puzzle

Surprising results of patch testing with the baseline series in patients with photocontact allergy to ketoprofen

The importance of propolis in patch testing--a multicentre survey

Clinical update on contact allergy